We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

Nasdaq:VRTX

Vertex Pharmaceuticals Incorporated (VRTX)

Nasdaq • VRTX • US92532F1003

549.04Last close

Market Closed

Trading Signals

ORTEX Data Highlights

As of Nov 3, 2026, ORTEX estimates 1.8% of free float is sold short, 2.8 days to cover, cost to borrow 0.48%.

Market Cap

139b USD | # 149 in US

Volume

1.24m shares | 648.23m USD

Shares Outstanding

253.46m

Free Float Shares

99.69% | 252.68m

DB:VX1|

XTRA:VX1|

LSE:0QZU|

BOVESPA:VRTX34|

BIT:1VRTX|

BASE:VRTX|

BASE:VRTXD|

WBAG:VRTX

News

VRTX key data

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has a market capitalization of $139.2B. Last close $549.04 (as of 2026-11-05); 52-week range $406.67 to $568.67. ORTEX data as of 2026-11-03: short interest is 1.76% of free float, 2.8 days to cover and the average cost to borrow is 0.48%.

VRTX news on ORTEX News
ORTEX News
ORTEX public data
ORTEX Charts
ORTEX API

© 2026 ORTEX Technologies Ltd.